Tylah Tully chats with Island Pharmaceuticals (ASX:ILA) managing director Dr David Foster after the company expanded its ...

Island will now focus on using the FDA’s animal rule to advance the Galidesivir program towards a new drug application (NDA), ...

The vaccines are intended to be developed for use against Marburg virus and Sudan ebolavirus, two hemorrhagic fevers in the ...

The US Department of Health and Human Services is weighing whether to fund new Marburg and Sudan Ebola virus vaccines even as Secretary Robert F. Kennedy Jr. overhauls the US immunization landscape, ...

Malawi at forefront of disease detection and pandemic preparedness in Africa after launching multi-pathogen genomic ...

The updated strategy serves as a comprehensive roadmap through 2030, outlining how Malawi will integrate genomic technologies ...

The Malawi Ministry of Health, launched its updated plan for the implementation of its Genomic Surveillance Strategy that was produced with technical support from the Africa Centres for Disease ...

POTUS threatens a foreign drug tariff, but gives Big Pharma more time to shift production onshore ASX drug makers say they ...

For this reason, the team led by Tobias Erb at the Max Planck Institute in Marburg set out to create a new, efficient ...

Anti-viral drug development company Island Pharmaceuticals (ASX: ILA) has expedited its US$550,000 acquisition of the ...

Island Pharmaceuticals Ltd (ASX: ILA), an Australian antiviral drug development company focused on areas of unmet need for ...

The latest international news, investigations and analysis from Africa, the Americas, Asia, Australia, Canada, Europe, the Middle East and the U.K.